Hervé Desmorat
About
In The Last Decade
Hervé Desmorat
23 papers receiving 868 citations
Peers
Comparison fields: 5 of 56
- Hepatology 739
- Epidemiology 685
- Surgery 312
- Gastroenterology 187
- Pathology and Forensic Medicine 73
Countries citing papers authored by Hervé Desmorat
This map shows the geographic impact of Hervé Desmorat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Desmorat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Desmorat more than expected).
Fields of papers citing papers by Hervé Desmorat
This network shows the impact of papers produced by Hervé Desmorat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Desmorat. The network helps show where Hervé Desmorat may publish in the future.
Co-authorship network of co-authors of Hervé Desmorat
This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Desmorat. A scholar is included among the top collaborators of Hervé Desmorat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Desmorat. Hervé Desmorat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 148 | |
| 5 | [Assessment of quality of life in chronic hepatitis C: effect of treatment]. | 3 |
| 6 | 50 | |
| 7 | [Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]. | 9 |
| 8 | 30 | |
| 9 | [Do general practitioners want to manage chronic hepatitis C and take part in hepatitis C health networks? A national survey]. | 5 |
| 10 | 0 | |
| 11 | 146 | |
| 12 | 4 | |
| 13 | 52 | |
| 14 | 55 | |
| 15 | 14 | |
| 16 | 149 | |
| 17 | 20 | |
| 18 | [Obstructive intramural hematoma of the esophagus. A rare complication of endoscopic sclerotherapy of esophageal varices]. | 4 |
| 19 | 154 | |
| 20 | [Irregular hepatic steatosis. Clinical and imaging study of 6 cases]. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.